Tests fish oil doses in pregnant women to study early childhood asthma
Tests higher-dose fish oil in pregnant adults to study childhood asthma risk.
Plain-language title generated from the registry record
Registry title: Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Key facts
- Where
- Gentofte Municipality, DenmarkSee the site
- Phase
- Phase 3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT06560255, who can take part
Where in Denmark
- Copenhagen University Hospital of CopenhagenGentofte Municipality, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Professor Klaus Bønnelykke
- Trial code
- NCT06560255
- Record updated
- 30 September 2025
- Original description
The overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could reduce the risk of disease development.Read full original descriptionShow less
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma (FREYA)
The overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could reduce the risk of disease development.
Pregnant Danish women before week 26 with blood levels of EPA+DHA below 4.7% of total fatty acids; No planned use of fish oil supplementations; No endocrine-, heart-, kidney- or auto-immune disorders; No disorders requiring treatment with blood thinning medication.